Nature Search

A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees

Antonella Folgori
Stefania Capone
Alfredo Nicosia
Research05 Feb 2006
Nature Medicine

Volume: 12, P: 190-197
Waist-to-calf circumference ratio as a potential indicator of diabetes risk: results from the Longevity Check-Up (Lookup) 8+

Stefano Cacciatore
Anna Maria Martone
Maria Zuppardo
ResearchOpen Access21 Nov 2024
Scientific Reports

Volume: 14, P: 1-11
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results

Chiara Agrati
Concetta Castilletti
Stefania Capone
ResearchOpen Access24 Sept 2022
npj Vaccines

Volume: 7, P: 1-11
Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade

Vaccination against neo-antigens has resulted in an effective antitumor response in several models. Here, the authors show that delivery of larger sets of neo-antigens using an adenovirus-based vaccination platform, results in much better tumor protection when combined with checkpoint blockade in a mouse model of advanced disease.

Anna Morena D’Alise
Guido Leoni
Elisa Scarselli
ResearchOpen Access19 Jun 2019
Nature Communications

Volume: 10, P: 1-12
Protective CD8⁺ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

Induction of protective immunity mediated by CD8⁺ T cells has been a long sought goal in vaccinology. Here, Ewer et al. report induction of protective efficacy against Plasmodium falciparummalaria in a phase IIa prime-boost vaccine trial where efficacy correlates strongly with induced CD8 T-cell responses.

Katie J. Ewer
Geraldine A. O’Hara
Adrian V. S. Hill
ResearchOpen Access28 Nov 2013
Nature Communications

Volume: 4, P: 1-10
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP

Carly M. Bliss
Georgina Bowyer
Katie J. Ewer
ResearchOpen Access21 Feb 2018
Scientific Reports

Volume: 8, P: 1-17
Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19

Chiara Agrati
Stefania Capone
Antonella Folgori
ResearchOpen Access04 Nov 2021
npj Vaccines

Volume: 6, P: 1-4
Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

A chimpanzee adenovirus-based vaccination approach elicits acute and long-term protection against ebolavirus challenge in nonhuman primates.

Daphne A Stanley
Anna N Honko
Nancy J Sullivan
Research07 Sept 2014
Nature Medicine

Volume: 20, P: 1126-1129
Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans

Stefania Capone
Anthony Brown
Leo Swadling
ResearchOpen Access12 Oct 2020
npj Vaccines

Volume: 5, P: 1-14

Search

Filter By:

Search

Quick links